Heinz Ludwig, Executive Director at Wilhelminen Cancer Research Institute, shared a post on LinkedIn:
“Dear colleagues and friends,
It is a great pleasure to welcome you to the European Multiple Myeloma Academy 2026 here in Vienna. Over the next two days, we will explore the latest advances in myeloma biology, diagnostics, and treatment, and discuss how these developments can be translated into better patient care.
Our program brings together leading experts from across Europe to share new insights into disease mechanisms, risk stratification, innovative response assessment tools, and rapidly evolving therapeutic strategies — from frontline therapy to cellular and immune-based approaches.
I look forward to inspiring presentations, lively discussions, and the opportunity to learn from one another as we continue to push the boundaries of what is possible for our patients.
Warm regards,
Heinz.”
More posts featuring Heinz Ludwig.